This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Depocyt (Cytarabine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (42)
Death (6)
Life Threatening Events (9)
Disability (6)
Reports by Reaction Type
Headache (9),
Mucosal Inflammation (7),
Arachnoiditis (6),
Coma (6),
Hepatic Enzyme Increased (6),
Hyperkalaemia (5),
Deafness (5),
Pneumocystis Jiroveci Pneumonia (5),
Herpes Simplex (5),
Dysarthria (5),
Pyrexia (4),
Somnolence (4)
Below are a few examples of reports where side effects / adverse reactions may be related to Depocyt (Cytarabine). For a complete list or a specific selection of reports, please use the links above.
Possible Depocyt side effects in 21 year old female
Reported by a physician from United States on 2012-08-10
Patient: 21 year old female
Reactions: Aphasia, Hemiparesis, Leukoencephalopathy, Cerebrovascular Accident
Drug(s) suspected as cause:
Methotrexate
Indication: Multiple Myeloma
Depocyt
Dosage: inth
Indication: Multiple Myeloma
Possible Depocyt side effects in
Reported by a physician from Slovakia (Slovak Republic) on 2012-08-10
Patient:
Reactions: CNS Ventriculitis
Drug(s) suspected as cause:
Depocyt
Possible Depocyt side effects in 63 year old female
Reported by a physician from France on 2012-07-18
Patient: 63 year old female
Reactions: Neurotoxicity, Subarachnoid Haemorrhage, Posterior Reversible Encephalopathy Syndrome, Encephalopathy, Coma, Leukoencephalopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depocyt
Dosage: 40 mg, inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
End date: 2012-05-24
Gleevec
Dosage: 400 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
End date: 2012-05-26
Methotrexate Sodium
Dosage: 15 mg, inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
End date: 2012-05-24
Other drugs received by patient: Gentamicin; Fluconazole; Vincristine; Amikacin; Heparin; Cyclophosphamide; Valacyclovir Hydrochloride; Pyostacine; Imipenem and Cilastatin Sodium; Vfend; Mesna; Flagyl; Vancomycin; Cotrim; Ciprofloxacin Hydrochloride; Amphotericin B; Vibramycin; Rocephin; Methylprednisolone; Idarubicin HCL; Aspegic 1000; Colimycin; Tazobactam; Zyvox
Possible Depocyt side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-13
Patient: female
Reactions: Ischaemic Stroke, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Posterior Reversible Encephalopathy Syndrome, Sepsis, Oedema, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: 400 mg, daily
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
End date: 2012-05-26
Depocyt
Dosage: 40 mg, unk
Start date: 2012-05-24
Depocyt
Dosage: 40 mg, unk
Start date: 2012-05-17
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-17
Depocyt
Dosage: 40 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Methotrexate
Dosage: 15 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-24
Other drugs received by patient: Aspegic 1000; Bactrim DS; Tazobactam; Imipenem and Cilastatin Sodium; Fluconazole; Amikacin; Vincristine; Vibramycin D; Aspegic 1000; Fosphenytoin Sodium; Keppra; Vincristine; Gentamicin; Cyclophosphamide; Mesna; Colimycine; Pyostacine; Depakene; Iradubicin; Iradubicin; Fluconazole; Vincristine; Methylprednisolone; Ciprofloxacin Hydrochloride; Vancomycin; Mesna; Vfend; Iradubicin; Rocephin; Heparin Sodium; Flagyl; Amphotericin B; Zyvox; Clonazepam; Iradubicin; Valacyclovir Hydrochloride; Cyclophosphamide
Possible Depocyt side effects in 63 year old female
Reported by a physician from Austria on 2012-07-03
Patient: 63 year old female
Reactions: General Physical Health Deterioration, C-Reactive Protein Decreased, Asthenia, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Abraxane; Denosumab
Possible Depocyt side effects in 55 year old male
Reported by a physician from Belgium on 2012-06-21
Patient: 55 year old male
Reactions: Bone Marrow Failure, Toxicity To Various Agents, Aplasia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Folic Acid
Dosage: 200 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-03
End date: 2009-07-05
Methylprednisolone
Dosage: 100 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-02
End date: 2009-07-05
Cyclophosphamide
Dosage: 460 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-03
End date: 2009-07-05
Rituximab (Rituximab)
Dosage: 693 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-01
End date: 2009-07-01
Methotrexate Sodium
Dosage: 5500 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-02
End date: 2009-07-02
Adriamycin PFS
Dosage: 110 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-03
End date: 2009-07-03
Vincristine
Dosage: 2 mg;iv
Indication: Metastases To Meninges
Start date: 2009-07-02
End date: 2009-07-02
Depocyt
Dosage: 50 mg;inth
Indication: Metastases To Meninges
Start date: 2009-07-03
End date: 2009-07-03
Possible Depocyt side effects in 63 year old female
Reported by a physician from Austria on 2012-06-21
Patient: 63 year old female
Reactions: General Physical Health Deterioration, C-Reactive Protein Decreased, Asthenia, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Denosumab; Abraxane
Possible Depocyt side effects in 14 year old male
Reported by a consumer/non-health professional from Norway on 2012-06-10
Patient: 14 year old male
Reactions: C-Reactive Protein, Listless, Arachnoiditis, Deafness, Pyrexia, Headache, Somnolence, Fall, Neurotoxicity, Fatigue, Chest Pain, Coordination Abnormal, Sinusitis, Decreased Appetite, Ataxia, Cognitive Disorder, Mucosal Inflammation, Medulloblastoma Recurrent, Dysarthria, Metastases To Spine, Visual Impairment, Hypothyroidism, Neutropenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depocyt
Dosage: initially given every other week,then monthly,cumulative dose 650mg,resatarted after 18months
Indication: Medulloblastoma
Etoposide
Dosage: 25 mg/day on alternate days; max 100mg daily (50 mg/m2 cumu dose:11.5 g/m2 over 31 months
Administration route: Oral
Indication: Medulloblastoma
Celecoxib
Dosage: also taken 400mg bid 430mg/m2
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: also taken 50mg 3mg/kg
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Hydrogen Succinate; Dexamethasone
Possible Depocyt side effects in 63 year old female
Reported by a physician from Austria on 2012-06-08
Patient: 63 year old female
Reactions: General Physical Health Deterioration, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Abraxane; Denosumab
Possible Depocyt side effects in male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-05-30
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Confusional State, Listless, Arachnoiditis, Deafness, Pyrexia, Headache, Somnolence, Fall, Fatigue, C-Reactive Protein Increased, Chest Pain, Sinusitis, Decreased Appetite, Ataxia, Hypoaesthesia, Paraesthesia, Haematotoxicity, Mucosal Inflammation, Dysarthria, Anxiety, Neutropenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Etoposide
Dosage: 25mg every other day for the last 8 months; cumulative dose of 11.5 g/m2 over 31 months
Administration route: Oral
Thalidomide
Dosage: maximal dose 200mg daily (3 mg/kg)
Administration route: Oral
Indication: Medulloblastoma Recurrent
Etoposide
Dosage: maximal dose 100mg daily (50 mg/m2); cumulative dose of 11.5 g/m2 over 31 months
Administration route: Oral
Indication: Medulloblastoma Recurrent
Depocyt
Dosage: 50mg on alternate weeks, gradually increased to every other month; 3-month break after 7th course
Indication: Medulloblastoma Recurrent
Celecoxib
Dosage: maximal dose 400mg x 2 daily (430 mg/m2)
Administration route: Oral
Indication: Medulloblastoma Recurrent
Other drugs received by patient: Prednisolone Sodium Succinate; Dexamethasone
Possible Depocyt side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: female
Reactions: Vomiting, Nausea, Dizziness, Headache
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Dexamethasone
Possible Depocyt side effects in female
Reported by a physician from United States on 2012-05-29
Patient: female
Reactions: Back Pain
Drug(s) suspected as cause:
Depocyt
Possible Depocyt side effects in male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-04-26
Patient: male
Reactions: Dysarthria, Visual Impairment, Hypothyroidism, Ataxia, Deafness, Coordination Abnormal, Cognitive Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Temozolomide
Dosage: not reported
(Therapeutic Radiopharmaceuticals)
Dosage: 35 gy, unknown, other
Vincristine Sulfate
Dosage: not reported
Etoposide
Dosage: not reported
Cyclophosphamide
Dosage: not reported
Carboplatin
Dosage: 700 mg/m 2 milligram(s)/sq. meter
Cisplatin
Dosage: 80 mg/m 2 milligram(s)/sq. meter
Depocyt
Dosage: 50 mg milligram(s), intrathecal
(Lomustine)
Dosage: not reported
Possible Depocyt side effects in 16 year old female
Reported by a physician from Spain on 2012-04-19
Patient: 16 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 9 mg, 1x/day
Start date: 2011-02-16
End date: 2011-02-16
Depocyt
Dosage: 35 mg, 1x/day
Start date: 2011-02-16
End date: 2011-02-16
Cytarabine
Dosage: 3320 mg, 1x/day
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-02-12
End date: 2011-02-13
Dexamethasone
Dosage: 9 mg, 2x/day
Administration route: Oral
Start date: 2011-02-17
End date: 2011-02-20
Vincristine Sulfate
Dosage: 2 mg, 1x/day
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-02-08
End date: 2011-02-08
Asparaginase
Dosage: 1600 iu, 1x/day
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-02-13
End date: 2011-02-13
Voriconazole
Dosage: 360 mg, 2x/day
Indication: Aspergillosis
Start date: 2011-01-21
End date: 2011-01-22
Voriconazole
Dosage: 240 mg, 2x/day
Start date: 2011-01-22
End date: 2011-01-25
Dexamethasone
Dosage: 11 mg, 3x/day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-02-08
End date: 2011-02-14
Other drugs received by patient: Polaramine; Fluconazole; Methotrexate; Leucovorin Calcium; Furosemide; Omeprazole; Acetaminophen; Septra; Emla; Pyridoxine; Toriol; Maxidex; Zofran
Possible Depocyt side effects in 65 year old male
Reported by a physician from United States on 2012-04-17
Patient: 65 year old male
Reactions: Encephalitis Cytomegalovirus, Graft Versus Host Disease, Central Nervous System Lesion, Panencephalitis, CNS Ventriculitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Thiotepa
Indication: Diffuse Large B-Cell Lymphoma
Thiotepa
Indication: Myeloid Leukaemia
Thiotepa
Indication: Myelodysplastic Syndrome
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Myeloid Leukaemia
Rituximab
Indication: Myelodysplastic Syndrome
Idarubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Indication: Myelodysplastic Syndrome
Idarubicin HCL
Indication: Myeloid Leukaemia
Fludarabine Phosphate
Indication: Diffuse Large B-Cell Lymphoma
Fludarabine Phosphate
Indication: Myelodysplastic Syndrome
Fludarabine Phosphate
Indication: Myeloid Leukaemia
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Myelodysplastic Syndrome
Etoposide
Indication: Myeloid Leukaemia
Valaciclovir
Indication: Myeloid Leukaemia
Valaciclovir
Indication: Cytomegalovirus Infection
Valaciclovir
Indication: Myelodysplastic Syndrome
Depocyt
Indication: Diffuse Large B-Cell Lymphoma
Depocyt
Indication: Myelodysplastic Syndrome
Depocyt
Indication: Myeloid Leukaemia
Mitoxantrone
Indication: Myelodysplastic Syndrome
Mitoxantrone
Indication: Myeloid Leukaemia
Mitoxantrone
Indication: Diffuse Large B-Cell Lymphoma
Anti-Thymocyte Globulin Equine NOS
Indication: Diffuse Large B-Cell Lymphoma
Anti-Thymocyte Globulin Equine NOS
Indication: Myelodysplastic Syndrome
Anti-Thymocyte Globulin Equine NOS
Indication: Myeloid Leukaemia
Foscarnet
Indication: Myelodysplastic Syndrome
Foscarnet
Indication: Cytomegalovirus Infection
Foscarnet
Indication: Myeloid Leukaemia
Acyclovir
Indication: Myeloid Leukaemia
Acyclovir
Indication: Cytomegalovirus Infection
Acyclovir
Indication: Myelodysplastic Syndrome
Possible Depocyt side effects in 49 year old male
Reported by a physician from United Kingdom on 2012-04-11
Patient: 49 year old male
Reactions: Dyskinesia, Nuclear Magnetic Resonance Imaging Brain Abnormal, Headache
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Acyclovir; Imatinib Mesylate; Fluconazole; Cotrim
Possible Depocyt side effects in 21 year old male
Reported by a physician from Denmark on 2012-04-02
Patient: 21 year old male, weighing 120.0 kg (264.0 pounds)
Reactions: Arachnoiditis, Brain Oedema
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Tasigna
Possible Depocyt side effects in 20 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-02
Patient: 20 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Mucosal Inflammation, Herpes Simplex, Hyperkalaemia, Febrile Bone Marrow Aplasia, Hepatic Enzyme Increased
Drug(s) suspected as cause:
Doxorubicin HCL
Doxorubicin HCL
Dexamethasone
Depocyt
Indication: Burkitt's Lymphoma
Dexamethasone
Cytarabine
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Vincristine
Methotrexate
Indication: Burkitt's Lymphoma
Rituximab
Dosage: day 1
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Doxorubicin HCL
Cyclophosphamide
Methotrexate
Cytarabine
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Doxorubicin HCL
Vincristine
Methotrexate
Prednisone TAB
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Cytarabine
Cyclophosphamide
Dosage: a1-a3
Cyclophosphamide
Vincristine
Indication: Burkitt's Lymphoma
Vincristine
Doxorubicin HCL
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dexamethasone
Methotrexate
Cytarabine
Possible Depocyt side effects in 46 year old male
Reported by a physician from Norway on 2012-04-02
Patient: 46 year old male
Reactions: Neurotoxicity, Urinary Incontinence, Perineal Pain, Faecal Incontinence
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Rituximab; Sulfamethoxazole and Trimethoprim; Cyclophosphamide; Dexamethasone; Doxorubicin HCL; Dolcontin / 00036302 /; Zovirax / 00587301 /; Etoposide; Lactulose; Oxycodone HCL
Possible Depocyt side effects in 48 year old male
Reported by a physician from France on 2012-04-02
Patient: 48 year old male
Reactions: Agranulocytosis, Anaemia, Pain, Sepsis, Neoplasm Progression, Pyrexia, Headache, Thrombocytopenia, Prolymphocytic Leukaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ciprofloxacin
Dosage: 500 mg;bid;iv
Indication: Sepsis
Start date: 2012-02-18
End date: 2012-02-27
Depocyt
Dosage: 50 mg;qow;inth
Indication: Prolymphocytic Leukaemia
Start date: 2012-01-14
End date: 2012-01-31
Augmentin '125'
Dosage: 1 gm;tid;iv
Indication: Sepsis
Start date: 2012-02-18
End date: 2012-02-27
Other drugs received by patient: Coversyl / 00790702 /; Domperidone; Valacyclovir Hydrochloride; Adancor; Procoralan; Atenolol; Pantoprazole; Azathioprine; Atorvastatin; Clopidogrel Bisulfate and Aspirin; Bactrim; Gaviscon / 00237601 /
Possible Depocyt side effects in male
Reported by a physician from Germany on 2012-03-15
Patient: male
Reactions: Bulbar Palsy, Mydriasis, Urinary Incontinence, Faecal Incontinence, Visual Acuity Reduced, General Physical Health Deterioration, Muscular Weakness, Respiratory Paralysis, Paraesthesia, Cranial Nerve Disorder, Eyelid Ptosis, Areflexia, Dysaesthesia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depocyt
Dosage: 50 mg;1x;inth
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-14
End date: 2012-02-14
Depocyt
Dosage: 50 mg;1x;inth
Indication: Metastases To Meninges
Start date: 2012-02-14
End date: 2012-02-14
Other drugs received by patient: Aspirin; Pantoprazole; Avandia; Glimepiride; Dexamethasone; Methotrexate; Hydrochlorothiazide; Cytarabine; Ramipril
Possible Depocyt side effects in 63 year old female
Reported by a physician from Austria on 2012-03-15
Patient: 63 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Dysphagia, Dehydration, Hypophagia, Nervous System Disorder, Headache, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Levothyroxine Sodium; Fortecortin / 00016001 /; Hydal; Elomel; Pantoloc / 01263201 /; Acecomb; Zofran; Vertirosan / 00019501 /; Bisoprolol Fumarate
Possible Depocyt side effects in 63 year old female
Reported by a physician from Germany on 2012-02-14
Patient: 63 year old female
Reactions: Visual Acuity Reduced, CSF Pressure Increased, Papilloedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Oxazepam; Novalgin; Lyrica; Benalapril; Dexamethasone; Arimidex; Pantoprazole
Possible Depocyt side effects in 63 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09
Patient: 63 year old female
Reactions: Death, Vomiting, Neoplasm Malignant, Nausea, Diarrhoea, Hepatic Enzyme Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depocyt
Dosage: 6sep11,20sep11
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-23
End date: 2011-09-20
Sprycel
Dosage: stoppd on 6sep10 and restartd on oct2011-death(13 month)
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2010-06-05
Possible Depocyt side effects in
Reported by a physician from Italy on 2012-01-25
Patient:
Reactions: Vision Blurred, Headache
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Cyclophosphamide; Cytarabine; Etoposide; Dexamethasone; Vincristine; Doxorubicin HCL; Rituximab; Ifosfamide; Methotrexate
Possible Depocyt side effects in 58 year old male
Reported by a physician from Austria on 2012-01-17
Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Posturing, Vomiting, Restlessness, Body Temperature Increased, Aphasia, Coma, Hemiparesis, Disorientation, Disease Progression, Speech Disorder, Pleocytosis, Brain Oedema, Intracranial Pressure Increased, Hallucination, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Pantoprazole Sodium; Novaban; Dulcolax; Dipidolor; Klysmol; Folsan; Lovenox; Structokabiven / 05981101 /; Diclobene; Myostatin; CAL D Vita; Hydromorphone HCL; Zantac; Scopolamine; Seractil
Possible Depocyt side effects in 58 year old male
Reported by a physician from Austria on 2012-01-06
Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: General Physical Condition Abnormal, Arachnoiditis, Vomiting, Restlessness, Body Temperature Increased, Aphasia, Coma, Hemiparesis, Disorientation, Sopor, Speech Disorder, Apraxia, Pleocytosis, Hallucination, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Dulcolax; Seractil; Lovenox; Zantac; Dislobene; Hydromorphone HCL; Mycostatin; Dipidolor; Navoban; Folsan; Structokabiven / 05981101 /; CAL D Vita; Pantoloc / 012632204 /; Klysmol; Scopolamine
Possible Depocyt side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-28
Patient: 40 year old female
Reactions: Pulmonary Embolism, Encephalopathy, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2011-04-05
End date: 2011-04-05
Idarubicin Hydrochloride
Dosage: unk
Start date: 2011-04-05
End date: 2011-04-05
Depocyt
Dosage: 50 mg, unk
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2011-04-05
End date: 2011-04-05
Fludarabine Phosphate
Dosage: unk
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2011-04-05
End date: 2011-04-05
Other drugs received by patient: Neupogen
Possible Depocyt side effects in male
Reported by a physician from Norway on 2011-12-28
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Confusional State, Arachnoiditis, Ataxia, Deafness, Pyrexia, Hypoaesthesia, Headache, Somnolence, Fall, Paraesthesia, Anxiety, Dysarthria, C-Reactive Protein Increased, Chest Pain, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depocyt
Other drugs received by patient: Dexamethasone; Thalidomide; Celecoxib; Prednisolone; Etoposide
Possible Depocyt side effects in 20 year old male
Reported by a individual with unspecified qualification from Germany on 2011-12-16
Patient: 20 year old male
Reactions: Mucosal Inflammation, Pneumocystis Jiroveci Pneumonia, Hyperkalaemia, Herpes Simplex, Bone Marrow Failure, Hepatic Enzyme Increased
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg abs. in a1-a3
Cyclophosphamide
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Depocyt
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
|